Skip to main content
logo
CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Nov 5, 2026

CNBX Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Market Capitalization
0000425
Market Cap Growth
-26.95%43.59%-45.29%-91.76%-82.85%-3.36%
Enterprise Value
1212624
Last Close Price
0.000.000.010.023.4020.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
PS Ratio
--1.480.86142.76-
PB Ratio
--0.11-0.08-0.17-2.6213.81
P/TBV Ratio
-----13.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
EV/Sales Ratio
--10.874.00193.13-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Debt / Equity Ratio
-0.44-0.48-0.52-0.67-1.080.48
Net Debt / Equity Ratio
-0.43-0.47-0.51-0.60-1.00-0.28
Net Debt / EBITDA Ratio
--5.93-2.48-1.58-0.600.22
Net Debt / FCF Ratio
-7.51-6.90-5.17-10.79-0.980.21
Asset Turnover
--0.490.630.02-
Quick Ratio
0.000.010.010.050.051.09
Current Ratio
0.010.010.010.090.081.25
Return on Equity (ROE)
-----4289.36%-178.94%
Return on Assets (ROA)
-1709.09%-681.68%-137.42%-88.86%-94.92%-61.35%
Return on Capital Employed (ROCE)
16.10%10.90%23.50%46.20%181.00%-144.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Earnings Yield
-569.00%-113.36%-360.41%-1052.38%-87.05%-12.81%
FCF Yield
-80.06%-61.85%-127.26%-31.92%-39.30%-10.00%
Buyback Yield / Dilution
-2258.06%-199.69%-242.76%-621.77%-5.92%-2.95%